These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 37369775)

  • 1. Neurosteroids: mechanistic considerations and clinical prospects.
    Maguire JL; Mennerick S
    Neuropsychopharmacology; 2024 Jan; 49(1):73-82. PubMed ID: 37369775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R
    Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopregnanolone Mediates Affective Switching Through Modulation of Oscillatory States in the Basolateral Amygdala.
    Antonoudiou P; Colmers PLW; Walton NL; Weiss GL; Smith AC; Nguyen DP; Lewis M; Quirk MC; Barros L; Melon LC; Maguire JL
    Biol Psychiatry; 2022 Feb; 91(3):283-293. PubMed ID: 34561029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
    Rupprecht R
    Psychoneuroendocrinology; 2003 Feb; 28(2):139-68. PubMed ID: 12510009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.
    Uzunova V; Sampson L; Uzunov DP
    Psychopharmacology (Berl); 2006 Jun; 186(3):351-61. PubMed ID: 16249906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA
    Luscher B; Maguire JL; Rudolph U; Sibille E
    Trends Pharmacol Sci; 2023 Sep; 44(9):586-600. PubMed ID: 37543478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder.
    Cutler AJ; Mattingly GW; Maletic V
    Transl Psychiatry; 2023 Jun; 13(1):228. PubMed ID: 37365161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons.
    Gee KW; McCauley LD; Lan NC
    Crit Rev Neurobiol; 1995; 9(2-3):207-27. PubMed ID: 8581984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of GABAergic system in the antidepressant-like effects of chrysin (5,7-dihydroxyflavone) in ovariectomized rats in the forced swim test: comparison with neurosteroids.
    Cueto-Escobedo J; Andrade-Soto J; Lima-Maximino M; Maximino C; Hernández-López F; Rodríguez-Landa JF
    Behav Brain Res; 2020 May; 386():112590. PubMed ID: 32184157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relating neurosteroid modulation of inhibitory neurotransmission to behaviour.
    Belelli D; Phillips GD; Atack JR; Lambert JJ
    J Neuroendocrinol; 2022 Feb; 34(2):e13045. PubMed ID: 34644812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurosteroids and their function].
    Bicíková M; Hampl R
    Cas Lek Cesk; 2007; 146(3):223-6. PubMed ID: 17419304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroactive steroid actions at the GABAA receptor.
    Lan NC; Gee KW
    Horm Behav; 1994 Dec; 28(4):537-44. PubMed ID: 7729823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAergic neuroactive steroids: a new frontier in bipolar disorders?
    Carta MG; Bhat KM; Preti A
    Behav Brain Funct; 2012 Dec; 8():61. PubMed ID: 23253178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosteroids and neuroactive drugs in mental disorders.
    Pisu MG; Serra M
    Life Sci; 2004 May; 74(26):3181-97. PubMed ID: 15094320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; Schüle C; Zwanzger P; Rupprecht R
    Expert Rev Endocrinol Metab; 2006 Jul; 1(4):517-526. PubMed ID: 30290461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological markers of rapid antidepressant effects of allopregnanolone.
    Lambert PM; Lu X; Zorumski CF; Mennerick S
    J Neuroendocrinol; 2022 Feb; 34(2):e13023. PubMed ID: 34423498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosteroid biosynthesis down-regulation and changes in GABA
    Locci A; Pinna G
    Br J Pharmacol; 2017 Oct; 174(19):3226-3241. PubMed ID: 28456011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subunit dependent modulation of GABAA receptor function by neuroactive steroids.
    Maitra R; Reynolds JN
    Brain Res; 1999 Feb; 819(1-2):75-82. PubMed ID: 10082863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?
    Rupprecht R; Wetzel CH; Dorostkar M; Herms J; Albert NL; Schwarzbach J; Schumacher M; Neumann ID
    Mol Psychiatry; 2022 Jul; 27(7):2918-2926. PubMed ID: 35444254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.